SECsense Logo

AstraZeneca PLC's Form 6-K: Shareholder Voting Rights Update for September 2025

$AZN
Form 6-K
Filed on: 2025-09-02
Source
AstraZeneca PLC's Form 6-K: Shareholder Voting Rights Update for September 2025

The key information extracted from the financial report (Form 6-K) concerning AstraZeneca PLC is as follows:

  1. Filing Details:
  • Type: Form 6-K
  • Commission File Number: 001-11960
  • Reporting Period: For the month of September 2025
  1. Company Information:
  • Company Name: AstraZeneca PLC
  • Address: 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom
  1. Voting Rights Notification:
  • As of August 31, 2025:
    • Total Issued Share Capital with Voting Rights: 1,550,692,963 ordinary shares of US$0.25
    • Shares Held in Treasury: None
    • Total Number of Voting Rights: 1,550,692,963
  1. Regulatory Compliance:
  • This notification is made in accordance with the UK's Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. Shareholders may use the total voting rights figure to determine their notification obligations regarding interest in AstraZeneca PLC under the same rules.
  1. Company Overview:
  • AstraZeneca is a global biopharmaceutical company focusing on the discovery, development, and commercialization of prescription medicines in various areas including Oncology and Rare Diseases.
  • The company operates in over 125 countries.
  1. Contact Information:
  • Company Secretary: Matthew Bowden
  • Date of Report: September 1, 2025

This report serves to provide shareholders with relevant information regarding their voting rights and complies with regulatory requirements for transparency regarding share capital and voting rights.